Trump Again Unleashes on 'Cryin' Chuck Schumer
Ambassador Huckabee Blasts Weak European Leaders Backing Hamas
How Texas Gov. Greg Abbott Intends to Nuke the Dems' Plan to Block...
What CNN's Harry Enten Just Said About Trump Is Going to Drive Libs...
Secret Service Was About to Make a Baffling Move Until a GOP Senator...
Bill Maher Nails Who Zohran Mamdani Is...and He Knows It'll Help Republicans
What a Fired ABC News Reporter Just Said About Anti-Trump Media Bias Is...
Some Adult Entertainment Got Hurled Onto the Court During a WNBA Game...Literally
Comedy Always Evolves, and Colbert Almost Killed It
This Is How a Dating App Turned Romance Into a Battleground
The VP Harris Post-Mortem on Stephen Colbert (Yes, Kamala, the System Worked)
The Biggest Loserit
Democrats Are in Disastrous Shape As Midterms Loom
Trump: Sydney Sweeney's American Eagle Campaign Is the 'Hottest' Ad Around
Has Pressure on Advertisers to Leave X Hurt the Right’s Only Major Free...
OPINION

Ending the FTC’s War on Consumers

The opinions expressed by columnists are their own and do not necessarily represent the views of Townhall.com.
AP Photo/Alex Brandon, File

The Federal Trade Commission has grown out of control under the leadership of Chairwoman Lina Khan. During her reign, the agency that claims to stop unfair business practices repeatedly faces accusations of engaging in unfair practices of its own. Time and time again, the FTC stretches the truth and oversteps the limits of its regulatory powers. 

Advertisement

Khan’s record in court is impressive for its sheer futility. Anti-trust experts, legal scholars, and the Supreme Court find little merit in her novel legal theories. Khan and her agency suffered a particularly significant blow from the Supreme Court after trying to throw the book at one private company, and instead received a unanimous decision opening up easier constitutional challenge to the commission’s authority.

Now, Khan might even be trying to regulate affordable drugs out of the country without any empirical evidence to back up her big stick agenda. 

This month, the Biden Federal Trade Commission released a long-anticipated report two years in the making, concluding that Pharmacy Benefit Managers (PBMs), hired by businesses and governments to secure drug rebates, are responsible for high drugs prices and thereby require “urgent” regulations. 

Alas, the report is entirely without substance.

In her dissenting opinion, Commissioner Holyoak explained how a sweeping 2005 FTC investigation came to the opposite conclusion, finding that PBMs lower drug costs. That finding is consistent with a host of other research. For example, a 2019 Government Accountability Office report showed PBMs saved Medicare Part D a full $29 billion.

Advertisement

Might the market have fundamentally changed since then to justify the agency’s reversal? Anything’s possible, and a new, comprehensive analysis could help illuminate related policy debates. But as Holyoak noted in her dissent, the FTC did not conduct or even cite any form of empirical analysis to corroborate its new conclusion. 

Although the FTC issued subpoenas on billions of prescriptions over the last two years, somehow the commission never invited its own Bureau of Economics to weigh in. Instead, it opted to base its report on anonymous sources — mostly market competitors seeking to weaponize regulators to gain an unscrupulous edge — with no economic data to support its assertions.

To quote Holyoak directly: “To assert that market conditions have changed is one thing — but to ignore the 2005 report without conducting a new empirical analysis of market conditions or explaining why the findings, conclusions, and empirical work no longer apply is a different matter entirely.”

Unfortunately, the politically driven process irregularities mentioned by Holyoak have become standard occurrences at the FTC. Things have gotten so bad that career staff, even those who agree with Khan philosophically, are resigning in record numbers out of frustration with the commission morphing into an agent of partisan hackery instead of one guided by empirical research and sound legal theories. 

Last year, Rep. James Comer’s (R-KY) House Oversight Committee conducted several investigations into the agency’s lack of standards. Now, Congress must follow up on those findings with action, whether it be more subpoenas, withholding funding, or reforms bills that narrow the scope and scale of the commission’s authority. 

Advertisement

Lina Khan has been chasing non-existent white whales for almost four years. It’s long past time for Congress to rein in the FTC, prevent further overreach, and bring the agency back to its mission of protecting marketplace competition and stopping deceptive business practices. 

Brian Garst is Vice President of the Center for Freedom and Prosperity. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement